Asphaug L, Akslen LA, Blix ES, Boge B, et al. Cost-effectiveness of Prosigna for Adjuvant Treatment Decisions in Early Breast Cancer: Healthcare Sector and Societal Perspectives. Clin Breast Cancer 2025 Apr 15:S1526-8209(25)00102.
PMID: 40348620